ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center
December 06, 2024SD Biosensor, Inc.announced the signing of a tripartite memorandum of understanding (MOU) for the research and development (R&D) of new products targeting extensively drug-resistant tuberculosis using its Point-of-Care (POC) molecular diagnostic platform
Pharma Sources Insight January 2025
